ASA 2023 Annual Meeting Attendees,
thank you for visiting HemoSonics!
American Society of Anesthesiology
October 13-17, 2023
San Francisco, CA
Saturday, October 14, 11:30 am – 12:15 pm
Quantra, viscoelastic testing reimagined, bleeding management redefined
HemoSonics Quantra represents the next generation of viscoelastic testing (VET) for managing perioperative bleeding. This workshop will demonstrate how Quantra enhances bleeding management at the point-of-care providing rapid results, easy interpretation for clear therapeutic guidance. There will be a general overview, case examples and live whole blood testing.
Todd Allen; Clinical Development Director
Jonathan Chow, MD; Anesthesiology & Critical Care Medicine
Please visit HemoSonics Booth #1737 and see the
Quantra Hemostasis Analyzer
As your facility ramps up elective cardiac surgeries, goal-directed bleeding management and optimized use of blood products are of utmost importance. Whole-blood viscoelastic testing at the point of care has been proven to improve patient outcomes and reduce blood products usage and wastage. The Quantra Hemostasis Analyzer is the next-generation, closed-cartridge viscoelastic hemostatic assay optimized for point-of-care use in perioperative patients:
The Quantra is the only device on which we can operate safely without needing specialized rooms and a biohazard cabinet…
– Ekaterina Baryshnikova, PhD, IRCCS Policlinico San Donato, Milan, Italy
Request a Demo
Product Availability and Indications
The Quantra Hemostasis Analyzer, QPlus® and QStat® Cartridges, and their respective Quality Controls Level 1 and 2 are CE Marked for use with patients 18 years of age or older where an evaluation of their blood coagulation properties is desired. Coagulation evaluations are commonly used to assess clinical conditions in surgery (e.g. cardiovascular and trauma surgeries) to assess risk of hemorrhage and thrombosis before, during, and following the procedure. Product availability is subject to fulfillment of regulatory requirements in each market.